Bronchogen (AEDL Peptide)

Bronchogen is an experimental short-chain peptide associated with respiratory and bronchial tissue research. It is commonly described as a tetrapeptide with the sequence Ala-Glu-Asp-Leu (AEDL).

In experimental research, Bronchogen is investigated in connection with bronchial epithelial cell function, pulmonary tissue biology, cellular proliferation and differentiation, tissue homeostasis, and cellular regulatory mechanisms, providing a research tool for studying biological responses within respiratory tissues.

Research involving short peptides such as Bronchogen has also explored potential relationships with gene expression, cellular signaling, and tissue-specific regulatory mechanisms, making it of interest in respiratory and cellular biology research.

Evidence involving Bronchogen remains limited, particularly with respect to large-scale human clinical research. Experimental findings should therefore not be interpreted as established bronchial protection, improvement of lung function, or treatment of respiratory disease.

Livraison standard offerte dès 50 $ vers les États-Unis, le Canada, le Mexique et l'Europe. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.